Pulmonary toxicity of high-dose chemotherapy for breast cancer: A non-invasive approach to diagnosis and treatment

Bone Marrow Transplantation

Volumn 20, Issue 12, 1997, Pages 1063-1067

  Chap, L ^a,b   Shpiner, R ^a   Levine, M ^a   Norton, L ^a   Lill, M ^a   Glaspy, J ^a  

^a UCLA MEDICAL CENTER   (United States)

^b Division of Hematology Oncology   (United States)

Author keywords

Breast cancer; High dose chemotherapy; Peripheral blood progenitor cell; Pulmonary toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; BREAST CANCER; CLINICAL TRIAL; EARLY DIAGNOSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; LUNG ALVEOLUS OXYGEN TENSION; LUNG INFILTRATE; LUNG TOXICITY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OXIMETRY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCORING SYSTEM; STEROID THERAPY; THORAX RADIOGRAPHY;

EID: 0031451082     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701028     Document Type: Article

References (18)

1. Rowlings PA, Horowitz MM, Armitage JO et al. Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. Clin Transplants 1993; 101-108.
2. Peters WP, Ross M, Vrendenburgh JJ et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11: 1132-1143.
3. Saez RA, Selby GB, Slease RB et al. Autologous bone marrow transplantation for metastatic breast cancer. J Ok State Med Assoc 1994; 87: 405-410.
4. Todd NW, Peters WP, Ost AH et al. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1264-1270.
5. Seiden MV, Elias A, Ayash L et al. Pulmonary toxicity associated with high-dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens. Bone Marrow Transplant 1992; 10: 57-63.
6. Phillips GL, Fay JW, Herzig GP et al. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC 4366650 and cryopreserved autologous marrow transplantation for refractory cancer. Cancer 1983; 52: 1792-1802.
7. Padley SPG, Adler B, Hansell DM et al. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992; 46: 232-236.
8. Selker RG, Jacobs SA, Moore PB et al. 1,3-bis(2-chloroethyl)-1 -nitrosourea (BCNU)-induced pulmonary fibrosis. Neurosurgery 1980; 7: 560-565.
9. Aronin PA, Mahaley MS, Rudnick SA et al. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors. New Engl J Med 1987; 303: 183-188.
10. Durant JR, Norgord MJ, Murad TM et al. Pulmonary toxicity associated with bis-chloroethyl nitrosourea (BCNU). Ann Intern Med 1979; 90: 191-194.
11. Cooper JAD Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part I: cytotoxic drugs. Am Rev Respir Dis 1986; 133: 321-340.
12. Smith AC, Boyd MR. Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity. J Pharmacol Exp Ther 1984; 229: 658-663.
13. Gurtoo HL, Hipkens JH, Sharma SD. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res 1981; 41: 3584-3591.
14. Cooper JAD Jr, Merrill WW, Reynolds HY. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism. Possible mechanisms of pulmonary pharmacotoxicity. Am Rev Resp Dis 1986; 134: 108-114.
15. Sayegh A, Reece D, Barnett M et al. Interstitial pneumonitis (IP) following high-dose chemotherapy (CT) with cyclophosphamide, BCNU, etoposide ± cisplatin (CBV ± P) and autologous bone marrow transplantation (AuBMT) for advanced Hodgkin's disease (HD): incidence, risk factors and outcome. J Cell Biochem 1992; 205 (Suppl.): 16A (Abstr.).
16. Keane TJ, Van Dyk J, Rider WD. Idiopathic interstitial pneumonia following autologous bone marrow transplantation. Int J Radiat Oncol Biol Phys 1981; 7: 1365-1370.
17. Williams SF, Mick R, Dresser R et al. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. J Clin Oncol 1990; 7: 1824-1830.
18. Cherniak RM, Abrams J, Kalica AR. Pulmonary disease associated with breast cancer therapy. Am Rev Resp Dis 1994; 150: 1169-1173.